Anson Funds Management’s Pfizer PFE Stock Holding History

Anson Funds Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$5.76M	–	197
2023 Q4	$5.76M	Buy	+200,000	New	+$6.05M	0.71%	31

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Anson Funds Management's PFE Position: Q2 2025 in Review

Anson Funds Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 90,000 shares — an estimated $2.28M sold.

Anson Funds Management first reported a position in PFE in Q1 2024 and held it in 5 quarters. The position peaked at $3.18M in Q4 2024. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Anson Funds Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Anson Funds Management sold 90,000 Pfizer shares in Q2 2025, an estimated $2.28M.
Anson Funds Management first reported a position in Pfizer in Q1 2024 and held it in 5 quarters.
Anson Funds Management's Pfizer position peaked at $3.18M in Q4 2024.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Anson Funds Management's 13F filing for Q2 2025, filed 14 Aug 2025.